Results 221 to 230 of about 116,364,761 (277)

Antiviral potential of graphitic carbon nitride (g-C₃N₄) nanosheets against herpes simplex virus type 1. [PDF]

Virol J
Jwaziri AK, Khales P, Roshanzamir N, Salavatiha Z, Kiani SJ, Babaei R, Tavakoli A.   +6 more
europepmc   +1 more source

Herpes Simplex Virus Type 1 and Type 2 Western Blot Serology Test Results From 1999 to 2020 in a US Reference Laboratory. [PDF]

Sex Transm Dis
Hussein A, Fischer M, Valinetz E, Pergam SA, Selke S, Pepper G, Jerome KR, Greninger AL, Wald A, Johnston C.   +9 more
europepmc   +1 more source

Computational design and evaluation of multiepitope vaccines against herpes simplex virus type 1. [PDF]

Front Immunol
Zhao Z, Wang W, Pang J, Zhou B, Li X, Wang Y, Zheng K, Ren Z.   +7 more
europepmc   +1 more source

Comparison of Peganum harmala L. leaves extract nanoformulations against herpes simplex virus type 1 guided by network pharmacology analysis. [PDF]

Sci Rep
Abou-Taleb BA, Elbanan AM, Hammoda HM, Abdelwahab IA, Mohyeldin MM, Ghallab DS.   +5 more
europepmc   +1 more source

Association between herpes simplex virus type 1 and the risk of Alzheimer's disease: a retrospective case-control study. [PDF]

BMJ Open
Liu Y, Johnston C, Jarousse N, Fletcher SP, Iqbal S.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Herpes Simplex Virus Type 1 Pneumonia—A Review

Journal of Intensive Care Medicine, 2021
Background: Pneumonia due to herpes simplex virus (HSV) is uncommon but can be seen in immunocompromised patients and has been associated with poor prognosis in this population. Aim: The aim was to study the results, outcome and ...
Marlene Ersgaard Jellinge, Frank Hansen, John Eugenio Coia, Zhijun Song   +3 more
openaire   +3 more sources

Hemagglutination by herpes simplex virus type 1

Archives of Virology, 1990
The McIntyre and HSZP strains as well as clinical isolate of herpes simplex virus type 1 were found to agglutinate C57Bl/10su and CBA mouse red blood cells. The hemagglutinating activity was inhibited by antisera that neutralized the infectivity of the virus.
E, Trybała, Z, Larski, J, Wiśniewski
openaire   +2 more sources

A Novel Anti-Herpes Simplex Virus Type 1-Specific Herpes Simplex Virus Type 1 Recombinant

Human Gene Therapy, 1999
A recombinant herpes simplex virus (HSV) capable of inhibiting its own replication as well as the replication of wild-type virus would have greatly increased safety as a general purpose vector for in vivo gene transfer, antitumor therapy, and viral vaccine against HSV infection.
F, Yao, E, Eriksson
openaire   +2 more sources